Industry committee  We don't foresee any supply chain challenges with the serology tests at this time.

Industry committee  Yes, they're available in those jurisdictions.

Industry committee  I don't have the exact numbers, Nathaniel. I can check for that and get that to the committee.

Industry committee  We're waiting on the licence from Health Canada that we submitted about three weeks ago. We've seen that in other jurisdictions it's typically taken about a month. We expect we will get it sooner rather than later, so we'll—

Industry committee  No. What we saw with the molecular testing was that it moved very quickly. That one was approved on March 16, and it was very fast. With the serology tests, there's been a little bit more of a delay. I wouldn't say “delay”: I think they're doing their due diligence on these ones.

Industry committee  Yes, maybe my colleague, Fanny, can expand a little as well, given her background. The first test that was approved was a molecular test. These have been the tests that have been used throughout the COVID pandemic. The serology test is more focused on determining whether folks h

Industry committee  Madam Chair and honourable members of the committee, on behalf of Hoffmann-La Roche, we want to thank you for the opportunity to speak today. We applaud the efforts of the federal government and of front-line health care workers to combat the spread of COVID-19 and to protect our